MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-18016

  1. 3,952 Posts.
    lightbulb Created with Sketch. 1352
    I would think that there would be considerable data already available through long term follow-up. Not only adverse trends would be looked at but positive trends also.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.